|
|||||||||
|
|
|||||||||
| Original Article | |||||||||
|
|
|||||||||
|
|
|||||||||
|
Pseudotumor Cerebri:
Categorical Disease
or Spectrum of Disease M. Sami Walida, e, Mazen Sanoufaa, Joe Sam Robinson, IIIb, Maragaret C. Boltjac, Joe Sam Robinson, Jrd
Manuscript
accepted for publication February
22,
2011
Abstract Background: Idiopathic intracranial hypertension (aka. pseudotumor cerebri) is a rare neurological disease of complex etiology that is more common in obese females. In this study, we investigate the main characteristics of our patient cohort with the diagnosis of idiopathic intracranial hypertension. Methods: The charts of pseudotumor cerebri patients that underwent treatment during the past five years at our institution in Central Georgia were retrospectively reviewed. We collected data on age, ethnicity, obesity, presence of papilledema, comorbidities, radiographic findings, laboratory findings and treatment. The modified Dandy criteria for the diagnosis of pseudotumor cerebri were applied on the patients. Results: The modified Dandy criteria applied to 23 patients with diagnosis of pseudotumor cerebri. The mean age was 35 and the range 15 to 62 years old. The average BMI was 39 and the range 22 to 62 kg/m2. All of the 23 patients were females. Fourteen patients (63.6%) had papilledema related to the diagnosis of idiopathic intracranial hypertension. Twelve (85.7%) patients of those with papilledema (14) were obese compared with five (55.6%) patients of those without papilledema (9). We had only two patients who had the full complex of symptoms including headaches, elevated opening pressure, papilledema and small cerebral ventricles. Six of seven diabetic patients had papilledema. Four of seven patients with arterial hypertension had papilledema. Two of three patients with chronic renal disease had papilledema. Four patients had low-lying cerebellar tonsils including three with papilledema.
Conclusions:
A cohort of patients with pseudotumor cerebri
diagnosis presents a
spectrum of the disease with increasing severity. A significant
percentage of these patients have metabolic comorbidities or
intracranial malformations that may explain the symptoms and should
be thoroughly investigated. Keywords: Idiopathic intracranial hypertension; Pseudotumor cerebri; Papilledema; Small cerebral ventricles
IntroductionIdiopathic intracranial hypertension is a rare neurological disease of complex etiology that is more common in obese females. Idiopathic intracranial hypertension, aka. pseudotumor cerebri (PTC), is characterized by increased intracranial pressure and papilledema in the absence of other neurologic localizing signs. Headaches and visual disturbances are the most common manifestations of the disease. The incidence of PTC in the general population is around 1 : 100,000, whereas in obese women aged 15 - 44 it is more common, at 10 - 20 : 100,000 [1]. PTC also occurs in approximately one in 1000 pregnancies [2].
In this
study, we investigate the main
characteristics of our patient cohort with
the diagnosis of idiopathic intracranial hypertension. Materials and MethodsThe charts of pseudotumor cerebri patients that underwent treatment during the past five years at our institution in Central Georgia were retrospectively reviewed. We collected data on age, ethnicity, obesity (BMI ≥ 30 kg/m2), presence of papilledema, comorbidities, radiographic findings, laboratory findings and treatment.
The Dandy criteria
[3,
4] for
the diagnosis of pseudotumor cerebri were applied on the patients:
(1) Signs and symptoms of increased intracranial pressure (headache,
nausea, vomiting, transient obscurations of vision, papilledema);
(2) Normal neurological exam, except for possible 6th nerve paresis;
(3) Elevated cerebrospinal fluid pressure (> 250 mm H2O) with normal
constituents; (4) Neuroimaging excluding a mass lesion or
hydrocephalus. Results
The modified Dandy criteria applied to 23 patients
with diagnosis of PTC.
The mean age was 35 and the range 15 to 62 years old. The average
BMI was 39 and the range 22 to 62 kg/m2.
All of the 23 patients were females.
Eleven were Afro-Americans and seven
Caucasians and the rest of mixed race.
Six patients reported being smokers. All of the 23 patients
complained of headaches and twenty complained of blurred vision at
the time of their presentation.
Fourteen patients (63.6%) had papilledema related to the diagnosis
of idiopathic intracranial hypertension (Fig.
1).
Discussion
PTC typically affects obese females of reproductive
age. An untypical patient may be a man, a child or a thin person in
which case an organic cause of increased intracranial pressure
should be first sought [5].
PTC’s etiology is not well understood. Many theories exist on PTC’s
pathomechanism. The mainstream of clinical research link this
disease to the water retention effect of estrogens on the central
nervous system [5,
6].
However, this theory is contradicted by reports of PTC occurrence in
males or in females with Turner’s syndrome [7,
8]. Less
popular theories talk about disturbances in the hypothalamic-hypophyseal-ovarian
axis in response to stressful triggers, an allergic
Jarisch-Herxheimer-type reaction to some undetermined infectious or
noninfectious stimuli or theories that incriminate thrombophilia
and/or hypofibrinolysis that lead to microthrombi in the choroid
plexus leading to decreased drainage of the cerebrospinal fluid
(CSF) and increased intracranial pressure [9-11].
The last theory seems to confuse intracranial hypertension due to
increased CSF pressure with increased intracranial pressure due to
increased volume of brain tissue. The definition of idiopathic
intracranial hypertension requires the absence of any focal lesion
that may cause an increase in intracranial pressure or
ventriculomegaly. Thus, increased intracranial pressure that is
associated with ventriculomegaly is called hydrocephalus and not
pseudotumor cerebri, aka. idiopathic intracranial hypertension,
implying that no apparent focal cause of increased intracranial
pressure can be identified. Hydrocephalus with increasing
intracranial pressure implies a problem with the production or
drainage of the CSF. However, in pseudotumor cerebri, the brain
tissue itself is swollen due to intracellular or intercellular water
retention. This increases the opening pressure of lumbar puncture by
contiguity and manifests itself ophthalmologically with papilledema.
Additionally, the posterior lobe of the pituitary gland located in
the sella turcica may be affected by the increased intracranial
pressure causing increased secretion of the antiduiretic hormone
which may further exacerbate the situation.
The term “benign intracranial hypertension” was first used by Foley [13] then was advocated by Weisberg [14] and even used by more recent authors [15-17]. This designation should be avoided, however, because the condition may be associated with severe debilitating visual loss in as many as 25% of patients [18, 19], and therefore it is not always “benign”. Instead, experts today advocate the use of the more accurate term “idiopathic intracranial hypertension”. However, even this description is not accurate because most of these patients are obese females and therefore the cause is not totally unknown (i.e. not idiopathic). Pseudotumor cerebri patients should be scrupulously interviewed and investigated to reveal any physiologic deviations or intracranial malformations that may explain weight gain, water retention and symptoms of increased intracranial pressure. If manageable metabolic or organic aberrances are discovered then the trigger of increased intracranial pressure should be treated before applying the diagnosis of “Idiopathic Intracranial Hypertension”. Inferior tonsillar displacement, for example, may be detected on magnetic resonance imaging in a significant percentage of PTC patients possibly representing a secondary form of PTC which may benefit from correction of ITD to restore normal intracranial pressure [20]. Another simple example of secondary etiology is the development of PTC as a rare complication of iron deficiency anemia [21]. Increased RDW may be the earliest evidence of the development of an iron-deficient erythropoiesis in the peripheral blood smear. The diagnosis of pseudotumor cerebri can be difficult in atypical cases where some elements of the Dandy criteria are missing, for example, how to differentiate functional headaches with situational elevation of opening pressure from atypical pseudotumor cerebri without papilledema [22]. In light of this, it is useful to quote Dr. F. H. Sklar’s first paragraph in the introduction of his chapter on Pseudotumor Cerebri in Neurosurgery, 2nd Edition, 1996, “Unfortunately, the term has been used to describe patients with a potpourri of clinical conditions. Unrelated disease mechanisms may share similar clinical presentations. Accordingly, pseudotumor cerebri likely represents multiple and different disease entities. This nonspecificity of pathophysiology has most certainly been a major contributing factor to confusion and controversy associated with this topic.” [23]. |
|||||||||
|
|
|||||||||
| References | |||||||||
| 1. |
Ivancic R, Pfadenhauer K. Pseudotumor cerebri after
hormonal emergency contraception. Eur Neurol 2004;52(2):120. [Medline] [CrossRef] |
| 2. |
Katz VL, Peterson R, Cefalo RC. Pseudotumor cerebri and
pregnancy. Am J Perinatol 1989;6(4):442-445. [Medline] [CrossRef] |
| 3. |
Smith JL. Whence pseudotumor cerebri? J Clin
Neuroophthalmol 1985;5(1):55-56. [Medline] |
| 4. |
Wall M. Idiopathic intracranial hypertension. Neurol Clin
1991;9(1):73-95. [Medline] |
| 5. |
Bagga R, Jain V, Das CP, Gupta KR, Gopalan S, Malhotra S.
Choice of therapy and mode of delivery in idiopathic intracranial
hypertension during pregnancy. MedGenMed 2005;7(4):42. [Medline] |
| 6. |
Donaldson JO, Horak E. Cerebrospinal fluid oestrone in
pseudotumour cerebri. J Neurol Neurosurg Psychiatry 1982;45(8):734-736.
[Medline] [CrossRef] |
| 7. |
Digre KB, Corbett JJ. Pseudotumor cerebri in men. Arch
Neurol 1988;45(8):866-872. [Medline] |
| 8. |
Donaldson JO, Binstock ML. Pseudotumor cerebri in an
obese woman with Turner syndrome. Neurology 1981;31(6):758-760. [Medline] |
| 9. |
Powell JL. Pseudotumor cerebri and pregnancy. Obstet
Gynecol 1972;40(5):713-718. [Medline] |
| 10. |
Barber SG, Garvan N. Is "benign intracranial
hypertension" really benign? J Neurol Neurosurg Psychiatry
1980;43(2):136-138. [Medline] [CrossRef] |
| 11. |
Finsterer J, Kuntscher D, Brunner S, Krugluger W.
Pseudotumor cerebri from sinus venous thrombosis, associated with
polycystic ovary syndrome and hereditary hypercoagulability. Gynecol
Endocrinol 2007;23(3):179-182. [Medline] [CrossRef] |
| 12. |
Corbett JJ, Thompson HS. The rational management of
idiopathic intracranial hypertension. Arch Neurol 1989;46(10):1049-1051.
[Medline] |
| 13. |
Foley J. Benign forms of intracranial hypertension; toxic
and otitic hydrocephalus. Brain 1955;78(1):1-41. [Medline] [CrossRef] |
| 14. |
Weisberg LA. Benign intracranial hypertension. Medicine
(Baltimore) 1975;54(3):197-207. [Medline] [CrossRef] |
| 15. |
Greitz D, Hannerz J, Rahn T, Bolander H, Ericsson A. MR
imaging of cerebrospinal fluid dynamics in health and disease. On the
vascular pathogenesis of communicating hydrocephalus and benign
intracranial hypertension. Acta Radiol 1994;35(3):204-211. [Medline] [CrossRef] |
| 16. |
Malozowski S, Tanner LA, Wysowski DK, Fleming GA, Stadel
BV. Benign intracranial hypertension in children with growth hormone
deficiency treated with growth hormone. J Pediatr 1995;126(6):996-999.
[Medline] [CrossRef] |
| 17. |
Schwarz S, Husstedt IW, Georgiadis D, Reichelt D, Zidek
W. Benign intracranial hypertension in an HIV-infected patient: headache
as the only presenting sign. AIDS 1995;9(6):657-658. [Medline] |
| 18. |
Corbett JJ, Savino PJ, Thompson HS, Kansu T, Schatz NJ,
Orr LS, Hopson D. Visual loss in pseudotumor cerebri. Follow-up of 57
patients from five to 41 years and a profile of 14 patients with
permanent severe visual loss. Arch Neurol 1982;39(8):461-474. [Medline] |
| 19. |
Lessell S, Rosman NP. Permanent visual impairment in
childhood pseudotumor cerebri. Arch Neurol 1986;43(8):801-804. [Medline] |
| 20. |
Banik R, Lin D, Miller NR. Prevalence of Chiari I
malformation and cerebellar ectopia in patients with pseudotumor
cerebri. J Neurol Sci 2006;247(1):71-75. [Medline] [CrossRef] |
| 21. |
Tugal O, Jacobson R, Berezin S, Foreman S, Brudnicki A,
Godine L, Davidian MM, et al. Recurrent benign intracranial hypertension
due to iron deficiency anemia. Case report and review of the literature.
Am J Pediatr Hematol Oncol 1994;16(3):266-270. [Medline] [CrossRef] |
| 22. |
Digre KB, Nakamoto BK, Warner JE, Langeberg WJ, Baggaley
SK, Katz BJ. A comparison of idiopathic intracranial hypertension with
and without papilledema. Headache 2009;49(2):185-193. [Medline] [CrossRef] |
| 23. | Sklar FH. Pseudotumor Cerebri. In: Neurosurgery. Wilkins RH, Rengachary SS (Eds.). New York : McGraw-Hill, Health Professions Division, c1996. |
Digital Object Identifier (DOI):10.4021/jnr103e
About
DOI and
CrossRef
Journal of Neurology Research is a member of CrossRef.




